AI assistant
Sending…
Kindly MD, Inc. — Director's Dealing 2026
Feb 24, 2026
32944_dirs_2026-02-24_b373fd2d-9569-4c9c-8388-67c3d39fb44a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nakamoto Inc. (NAKA)
CIK: 0001946573
Period of Report: 2026-02-20
Reporting Person: Creighton Andrew John (Chief Commercial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-20 | Stock Option | $0.43 | A | 1685500 | Acquired | 2035-10-30 | Common Stock (1685500) | Direct |
Footnotes
F1: Reflects 1,685,500 fully vested stock options, exercisable on a one-for-one basis for common stock of the Issuer, par value $0.001, which were assumed by the Issuer pursuant to that certain Agreement and Plan of Merger, dated February 16, 2026, by and among the Issuer, BTC Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Issuer, BTC Inc., a Delaware corporation, and the stockholder representative party thereto.
More from Kindly MD, Inc.
Regulatory Filings
2026
May 22
Earnings Release
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
Apr 24
Capital/Financing Update
2026
Apr 24
Capital/Financing Update
2026
Apr 17
Regulatory Filings
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Capital/Financing Update
2026
Apr 9